Delivery Order SPE2DB22D1017-SPE2DB25FH0BX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate 2.5 mg chewable tablets (100-count units) with a contract value of $1,620.98. The award was made on July 21, 2025, with an ultimate completion date of July 22, 2025, under a firm fixed-price delivery order structure. The contract was competitively awarded with no set-aside designation, and performance is based at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100 count) under a firm fixed price contract valued at $3,736.67. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Methylphenidate 5 mg chewable tablets in quantities of 100 units, with a contract ceiling value of $1,231.28. This firm fixed-price delivery order, which is scheduled for completion by August 19, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate 5 mg chewable tablets (100-count units) valued at $3,794.71 with a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for completion by August 1, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The vendor will perform fulfillment from its Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,852.00 for 100 tablets of Methylphenidate 2.5 mg chewable formulation. This non-set-aside contract was competitively awarded on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,387.40 to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg tablets (100 count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Methylphenidate is a central nervous system stimulant commonly used in military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,149.78 to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate 5 mg chewable formulation, with an ultimate completion date of July 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER(LA) 20mg tablets (100-count units) under a firm fixed-price contract valued at $1,511.72. This is a non-set-aside competitive award with an ultimate completion date of July 29, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is the vendor's corporate office in...
- The Defense Logistics Agency awarded a $1,471.36 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $3,150.33. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the federal pharmaceutical procurement process. The order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FH0BXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,076.21 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 10 mg chewable tablets in quantities of 100 units. This contract award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract mechanism that covers specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/19/25 |